Stem Cell Research & Therapy,
Journal Year:
2025,
Volume and Issue:
16(1)
Published: March 26, 2025
Traditional
toxicological
assessment
relied
heavily
on
2D
cell
cultures
and
animal
models
of
study,
which
were
inadequate
for
the
precise
prediction
human
response
to
chemicals.
Researchers
have
now
shifted
focus
organoids
assessment.
Organoids
are
3D
structures
produced
from
stem
cells
that
mimic
shape
functionality
organs
a
number
advantages
compared
traditional
study.
They
capacity
replicate
intricate
cellular
microenvironment
in
vivo
interactions.
offer
physiologically
pertinent
platform
is
useful
researchers
monitor
responses
more
realistic
manner
evaluate
drug
toxicity.
Additionally,
can
be
created
unique
patient,
allowing
individualized
research
providing
understanding
inter-individual
heterogeneity
responses.
Recent
developments
use
gut
liver
xenobiotics
(environmental
toxins
drugs)
reviewed
this
article.
Gut
reveal
potential
damage
digestive
system
how
affect
nutrient
absorption
barrier
function.
Liver
primary
site
detoxification
metabolism
xenobiotics,
usually
routed
gut.
Hence,
these
linked
crucial
evaluating
chemical
or
pollutant
induced
organ
toxicity,
forecasting
their
pharmacokinetics.
When
incorporated
into
development
process,
organoid
improve
accuracy
efficiency
safety
assessments,
leading
safer
effective
treatments.
We
also
discuss
limitations
using
organoid-based
assays,
future
prospects,
including
need
standardized
protocols
overcoming
reproducibility
issues.
Frontiers in Artificial Intelligence,
Journal Year:
2024,
Volume and Issue:
6
Published: Jan. 5, 2024
Human
brain
organoids,
aka
cerebral
organoids
or
earlier
"mini-brains",
are
3D
cellular
models
that
recapitulate
aspects
of
the
developing
human
brain.
They
show
tremendous
promise
for
advancing
our
understanding
neurodevelopment
and
neurological
disorders.
However,
unprecedented
ability
to
model
development
function
Frontiers in Cell and Developmental Biology,
Journal Year:
2023,
Volume and Issue:
11
Published: Nov. 13, 2023
Human
cerebral
organoids
(HCOs)
are
model
systems
that
enable
researchers
to
investigate
the
human
brain
in
ways
had
previously
been
impossible.
The
emergence
of
HCOs
was
accompanied
by
both
expert
and
layperson
discussions
concerning
possibility
these
novel
entities
developing
sentience
or
consciousness.
Such
concerns
reflected
deliberations
about
how
handle
regulate
their
use.
This
perspective
article
resulted
from
an
international
interdisciplinary
research
retreat
"Ethical,
Legal
Social
Aspects
Cerebral
Organoids
Governance
Germany,
United
Kingdom
States",
which
took
place
Tübingen,
August
2022.
focused
on
whether
HCO
requires
new
ethical
regulatory
approaches.
It
addressed
epistemic
issues
around
detection
theorisation
consciousness,
moral
status
conduct,
difficulties
for
legislation
guidelines
managing
entities,
public
engagement.
Cambridge Quarterly of Healthcare Ethics,
Journal Year:
2023,
Volume and Issue:
32(4), P. 542 - 554
Published: May 10, 2023
The
risk
of
creating
cerebral
organoids/assembloids
conscious
enough
to
suffer
is
a
recurrent
concern
in
organoid
research
ethics.
On
one
hand,
we
should,
apparently,
avoid
discovering
how
distinguish
between
organoids
that
it
would
be
permissible
(non-conscious)
and
impermissible
(conscious)
use
research,
since
if
successful
create
suffer.
the
other,
do
not,
persists
might
inadvertently
continue
cause
Moreover,
modeling
some
brain
disorders
may
require
inducing
stress
organoids,
unclear
eliminate
risk,
want
develop
effective
therapies.
We
are
committed
harm
avoidance
but
hamstrung
by
presumption
should
tell
us
clearly
when
suffering
occurs.
How
can
negotiate
this
challenge
maximize
therapeutic
benefits
research?
author
interrogates
challenge,
suggesting
tentative
way
forward.
Oxford University Press eBooks,
Journal Year:
2024,
Volume and Issue:
unknown
Published: July 19, 2024
Abstract
Can
octopuses
feel
pain
and
pleasure?
What
about
crabs,
shrimps,
insects,
or
spiders?
How
do
we
tell
whether
a
person
unresponsive
after
severe
brain
injury
might
be
suffering?
When
does
fetus
in
the
womb
start
to
have
conscious
experiences?
Could
there
even
rudimentary
feelings
miniature
models
of
human
brain,
grown
from
stem
cells?
And
what
AI?
These
are
questions
edge
sentience,
they
subject
enormous,
disorienting
uncertainty.
The
stakes
immense,
neglecting
risks
can
terrible
costs.
We
need
err
on
side
caution,
yet
it’s
often
far
clear
‘erring
caution’
should
mean
practice.
going
too
far?
not
doing
enough?
Edge
Sentience
presents
comprehensive
precautionary
framework
designed
help
us
reach
ethically
sound,
evidence-based
decisions
despite
our
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(8), P. 4233 - 4233
Published: April 11, 2024
Polymers
stand
out
as
promising
materials
extensively
employed
in
biomedicine
and
biotechnology.
Their
versatile
applications
owe
much
to
the
field
of
tissue
engineering,
which
seamlessly
integrates
engineering
with
medical
science.
In
medicine,
biomaterials
serve
prototypes
for
organ
development
implants
or
scaffolds
facilitate
body
regeneration.
With
growing
demand
innovative
solutions,
synthetic
hybrid
polymer
materials,
such
polyethersulfone,
are
gaining
traction.
This
article
offers
a
concise
characterization
polyethersulfone
followed
by
an
exploration
its
diverse
biotechnological
realms.
It
concludes
summarizing
significant
roles
advancing
both
medicine
biotechnology,
outlined
accompanying
table.
Biomaterials Research,
Journal Year:
2024,
Volume and Issue:
28
Published: Jan. 1, 2024
Tissue
damage
and
functional
abnormalities
in
organs
have
become
a
considerable
clinical
challenge.
Organoids
are
often
applied
as
disease
models
drug
discovery
screening.
Indeed,
several
studies
shown
that
organoids
an
important
strategy
for
achieving
tissue
repair
biofunction
reconstruction.
In
contrast
to
established
stem
cell
therapies,
high
relevance.
However,
conventional
approaches
limited
the
application
of
regenerative
medicine.
Engineered
might
capacity
overcome
these
challenges.
Bioengineering—a
multidisciplinary
field
applies
engineering
principles
biomedicine—has
bridged
gap
between
medicine
promote
human
health.
More
specifically,
bioengineering
been
accelerate
their
translation.
this
review,
beginning
with
basic
concepts
organoids,
we
describe
strategies
cultivating
engineered
discuss
multiple
modes
create
conditions
breakthroughs
organoid
research.
Subsequently,
on
reconstruction
presented.
Finally,
highlight
limitations
challenges
hindering
utilization
applications.
Future
research
will
focus
using
advanced
tools
personalized
Journal of Biological Engineering,
Journal Year:
2023,
Volume and Issue:
17(1)
Published: Aug. 17, 2023
Abstract
The
approval
of
anticancer
therapeutic
strategies
is
still
slowed
down
by
the
lack
models
able
to
faithfully
reproduce
in
vivo
cancer
physiology.
On
one
hand,
conventional
vitro
fail
recapitulate
organ
and
tissue
structures,
fluid
flows,
mechanical
stimuli
characterizing
human
body
compartments.
other
animal
cannot
typical
tumor
microenvironment,
essential
study
behavior
progression.
This
reviews
cancer-on-chips
as
most
promising
tools
model
investigate
microenvironment
metastasis.
We
also
described
how
cancer-on-chip
devices
have
been
developed
implemented
common
primary
cancers
their
metastatic
sites.
Pros
cons
this
technology
are
then
discussed
highlighting
future
challenges
close
gap
between
pre-clinical
clinical
studies
accelerate
new
therapies
humans.
Frontiers in Cell and Developmental Biology,
Journal Year:
2023,
Volume and Issue:
11
Published: Feb. 2, 2023
Cell-cell
interactions
underlay
organ
formation
and
function
during
homeostasis.
Changes
in
communication
between
cells
their
surrounding
microenvironment
are
a
feature
of
numerous
human
diseases,
including
metabolic
disease
neurological
disorders.
In
the
past
decade,
cross-disciplinary
research
has
been
conducted
to
engineer
novel
synthetic
multicellular
systems
3D,
organoids,
assembloids,
organ-on-chip
models.
These
model
systems,
composed
distinct
cell
types,
satisfy
need
for
better
understanding
complex
biological
mechanisms
underpinning
diseases.
this
review,
we
discuss
emerging
field
building
3D
application
modelling
cellular
at
play
We
report
recent
experimental
computational
approaches
capturing
cell-cell
as
well
progress
bioengineering
recapitulating
these
complexities
Medical Review,
Journal Year:
2024,
Volume and Issue:
4(2), P. 129 - 153
Published: March 13, 2024
Abstract
In
the
field
of
biomedical
research,
organoids
represent
a
remarkable
advancement
that
has
potential
to
revolutionize
our
approach
studying
human
diseases
even
before
clinical
trials.
Organoids
are
essentially
miniature
3D
models
specific
organs
or
tissues,
enabling
scientists
investigate
causes
diseases,
test
new
drugs,
and
explore
personalized
medicine
within
controlled
laboratory
setting.
Over
past
decade,
organoid
technology
made
substantial
progress,
allowing
researchers
create
highly
detailed
environments
closely
mimic
body.
These
can
be
generated
from
various
sources,
including
pluripotent
stem
cells,
specialized
tissue
tumor
cells.
This
versatility
enables
replicate
wide
range
affecting
different
organ
systems,
effectively
creating
disease
replicas
in
dish.
exciting
capability
provided
us
with
unprecedented
insights
into
progression
how
we
develop
improved
treatments.
this
paper,
will
provide
an
overview
progress
utilizing
as
preclinical
models,
aiding
understanding
providing
more
effective
addressing
diseases.